Clinical trial finds that oral drug MK-0616 substantially reduces ‘bad’ cholesterol
MK-016 could offer another potential option to achieve guideline-recommended LDL-C levels resulting in reduction of cardiovascular risk.
Read moreMK-016 could offer another potential option to achieve guideline-recommended LDL-C levels resulting in reduction of cardiovascular risk.
Read moreDr. Bjoern Burckhardt will use mass spectrometric imaging to identify potential new biomarkers and promising drug targets for human diseases.
Read moreYou can’t escape your genetics, but with a little help, you can be proactive and intervene. That is why researchers at Baylor College of Medicine’s Human
Read moreWhile thinking about your valentine may set your heart aflutter, negative psychological factors such as stress or depressive disorders can have a long-term impact on
Read moreCardiovascular disease remains the leading cause of pain, suffering and death in the United States, and despite tremendous advances in knowledge on prevention, treatment of
Read moreIn his lab at Baylor College of Medicine, Dr. Joshua D. Wythe and his colleagues conduct cardiovascular research covering the following areas: Vascular Development, trying
Read moreThe human gene ABL1 is well-known for its association with cancer. In this case, a piece of chromosome 9 containing the ABL1 gene and a
Read moreBy Ana María Rodríguez, Ph.D. Patients with autoimmune disease have a higher risk of developing atherosclerosis and cardiovascular disease. Although studies have shown that human atherosclerotic
Read moreMeet “Jim,” he is overweight, borderline diabetic, always sleepy and snores like a freight train at night. He suffers from obstructive sleep apnea, but that’s
Read moreTaking care of your heart and watching blood sugar can be hard in a world with fast food dollar menus, holiday dessert tables and hours
Read more